Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   PCE(x) 7.7819.7211.169.6413.69

What is the latest Price to Cash Earnings (PCE) ratio of BLISS GVS PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of BLISS GVS PHARMA is 7.78 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20237.78
Mar202219.72
Mar202111.16
Mar20209.64
Mar201913.69

How is Price to Cash Earnings (PCE) of BLISS GVS PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 7.78
-60.55
Mar2022 19.72
76.70
Mar2021 11.16
15.77
Mar2020 9.64
-29.58
Mar2019 13.69 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,295.1 Cr 7% 8.4% 63.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

7%

8.4%

63.2%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses